Holen Sie sich die Stockscreener-App
5.8125
5.28%
-0.3375
Schlusskurs vom Vortag:
$6.15
Offen:
$6.08
24-Stunden-Volumen:
182.10K
Relative Volume:
0.93
Marktkapitalisierung:
$370.22M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-76.41M
KGV:
-3.0273
EPS:
-1.92
Netto-Cashflow:
$-64.56M
1W Leistung:
-2.59%
1M Leistung:
+8.68%
6M Leistung:
-10.11%
1J Leistung:
-22.23%
1-Tages-Spanne:
$5.80
$6.23
1-Wochen-Bereich:
$5.46
$6.33
52-Wochen-Spanne:
$4.345
$7.73
Aura Biosciences Inc Stock (AURA) Company Profile
Firmenname
Aura Biosciences Inc
Sektor
Branche
Telefon
(617)500-8864
Adresse
80 GUEST STREET, BOSTON
Compare AURA vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
5.83 | 390.55M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.43 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.76 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
725.75 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.55 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.26 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-26 | Fortgesetzt | Evercore ISI | Outperform |
| 2025-05-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-07-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-27 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-04-17 | Fortgesetzt | BTIG Research | Buy |
| 2022-07-19 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Aura Biosciences Inc Aktie (AURA) Neueste Nachrichten
Aura Biosciences Touts Phase 3 bel-sar Momentum, Eyes Mid-Year Bladder Cancer Data at TD Cowen Conference - Yahoo Finance
AURA: Late-stage oncology programs show strong safety, efficacy, and market potential, with key data ahead - TradingView
Aura's Bel-sar — One Asset, Multiple Oncology Opportunities - RTTNews
Aura Biosciences (AURA) officer granted RSUs and 112,661-share option - Stock Titan
Aura Biosciences (AURA) officer receives RSU and option grants - Stock Titan
Large equity awards to Elisabet de los Pinos at Aura Biosciences (AURA) - Stock Titan
Aura Biosciences (AURA) CTO receives new stock option and RSU awards - Stock Titan
Aura Biosciences (AURA) grants stock options and RSUs to its CMO - Stock Titan
Aura Biosciences (AURA) SVP awarded 80,472 options and 44,528 RSUs - Stock Titan
Aura Biosciences Posts Q2 Cash Surge - AOL.com
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Wall Street Recap: Is Aura Biosciences Inc in a long term uptrend2025 Technical Overview & Risk Managed Investment Strategies - baoquankhu1.vn
Aura Biosciences, Inc. (AURA) Stock Analysis: A Biotech Gem With 235% Potential Upside - DirectorsTalk Interviews
AURA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aura Biosciences plans fireside chats at three March healthcare events - Stock Titan
Update Recap: Is Aura Biosciences Inc stock undervalued right now2025 Pullback Review & Capital Efficiency Focused Ideas - baoquankhu1.vn
Understanding Momentum Shifts in (AURA) - Stock Traders Daily
Aura Biosciences, Inc. (AURA) Stock Analysis: Assessing a Potential 300% Upside in Biotech Innovation - DirectorsTalk Interviews
Aura Biosciences Expands Evidence With New Patient-Reported Outcome Study in Eye Cancer - TipRanks
Ocular melanoma Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Delcath System, Aura Biosciences, Seagen, IDEAYA, Ascentage Pharma - Barchart.com
Aura Biosciences (NASDAQ:AURA) SVP Amy Elazzouzi Sells 8,549 Shares - MarketBeat
What makes Aura Biosciences (AURA) a new buy stock - MSN
Are Medical Stocks Lagging Assertio (ASRT) This Year? - Bitget
Can Aura Biosciences Inc. outperform under higher oil prices2025 Investor Takeaways & Growth Focused Entry Point Reports - mfd.ru
Is Aura Biosciences Inc. exposed to currency risksBreakout Watch & Growth Oriented Trade Recommendations - mfd.ru
What Makes Aura Biosciences (AURA) a New Buy Stock - Yahoo Finance
Aura Biosciences, Inc. (AURA) Stock Analysis: Unpacking a 259% Potential Upside in Biotech Innovation - DirectorsTalk Interviews
Aug Big Picture: Can Aura Biosciences Inc benefit from deglobalizationQuarterly Earnings Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn
Avoiding Lag: Real-Time Signals in (AURA) Movement - Stock Traders Daily
Should you buy the dip on Aura Biosciences Inc.2025 Valuation Update & Weekly High Conviction Ideas - mfd.ru
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Aura Biosciences, Inc. (AURA) Stock Analysis: A Biotech Player with a Potential Upside of 237% - DirectorsTalk Interviews
AURA Should I Buy - Intellectia AI
Discipline and Rules-Based Execution in AURA Response - Stock Traders Daily
Guidance Update: Can Aura Biosciences Inc deliver alphaTrade Entry Report & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intellia Therapeutics (NTLA) and Viridian Therapeutics (VRDN) - The Globe and Mail
Aura Biosciences, Inc. (AURA): Investor Outlook with a Remarkable 257.93% Potential Upside - DirectorsTalk Interviews
Following a 29% decline over last year, recent gains may please Aura Biosciences, Inc. (NASDAQ:AURA) institutional owners - simplywall.st
WhiteFiber Inc (WYFI) Announces $200 Million Convertible Notes Offering, Shares Drop 5.5% - intellectia.ai
WhiteFiber, T1 Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
We're Keeping An Eye On Aura Biosciences' (NASDAQ:AURA) Cash Burn Rate - Yahoo Finance
Why High Roller Technologies Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket - Benzinga
Los Pinos Elisabet De Sells 16,928 Shares of Aura Biosciences (NASDAQ:AURA) Stock - Defense World
Aura Biosciences SVP Amy Elazzouzi sells $7683 in stock By Investing.com - Investing.com Australia
Behavioral Patterns of AURA and Institutional Flows - Stock Traders Daily
Top Executive Makes a Big Move With Aura Biosciences Stock - TipRanks
Aura Biosciences CEO de los Pinos sells $82k in stock - Investing.com Canada
Aura Biosciences SVP Amy Elazzouzi sells $7683 in stock - Investing.com
Big Picture: How does Aura Biosciences Inc perform in inflationary periodsMarket Risk Analysis & Safe Entry Point Alerts - baoquankhu1.vn
Is Postal Realty Trust Inc. in a long term uptrendWeekly Profit Summary & Daily Growth Stock Tips - bollywoodhelpline.com
RSI Check: Why hedge funds are buying Aura Biosciences Inc stockPortfolio Return Summary & Verified Chart Pattern Signals - Bộ Nội Vụ
Finanzdaten der Aura Biosciences Inc-Aktie (AURA)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):